Leading a team consisting of one marketer and three technical consultants to provide expertise and focus on updating the infusion delivery consumable product line at BD. Supporting the $1.3 billion business group.• Defining the future "Global" portfolio and project roadmaps • Leading design inputs for development of the portfolio components and product configurations • Developing automated tools for collateral development and maintenance• Preparing commercial launch plans and launching of global products

Sr Global Commercial/Marketing Responsible for portfolio innovation, harmonization, and rationalization across the BD infusion delivery portfolio. Focused on simple, yet functional solutions.

Responsible for marketing and commercial aspects of global IV infusion consumable portfolio. (Upstream and Downstream marketing).

Responsible for product management and strategic market development of the Alere range of Point of Care Cardio-metabolic analyzers. Recognition received for focus within NSW rural and remote Indigenous cardiac health research group for community services support and access to POC testing.

Responsible for product management and strategic market development of the B. Braun range of infusion products.

Project managed and researched organizational quality improvement initiatives within the healthcare governance framework, aimed at improving clinical safety and clinical outcomes, aligning with legislation, regulations, and healthcare standards.

Responsible for country market development of Cardiac Point of Care products specifically Cardiac troponin AMI diagnosis and INR monitoring for Warfarin / A-fib / stroke management.Recognition received from South Australia (Flinders University) Integrated Cardiovascular Clinical Network SA (iCCnet SA) for POC support in reducing AMI mortality in Rural and Remote Australia.Exceeded State contract renewal goals and exceeded sales objective during tenure.

Managed US strategic cardiac portfolio (MSA team (7) and Physician KOL group (6 cardiologists)Responsible for product launches and growth to forecast as well as market development for novel testing areas in Cardiac IA portfolio: troponin (Tnt), B type natriuretic peptide (NT-proBNP), myoglobin, CKMB, and D-dimer. • Successful track record of leading a diverse, field based, medical scientific liaison team and contracted KOL physicians to above target performance over multiple years. • Set vision and strategy for maximizing upselling of reagents, driven through innovative Four Seasons and Cardiac care programs for recognition and focus within sales teams• Achieved stretch goals consistently throughout tenure in marketing leadership• Oversaw growth of immunoassay reagents to > $40M

Responsible for the development, implementation and strategic growth of Roche Cardiac Markerssuccessfully cultivating cardiac bio-marker clinical practice adoption.Facilitated and developed relationships with the medical/scientific community communicating scientific information on research developments and changes in standards of care and medical treatment.

Clinical Specialist Cardiac Assist Devices: Capital and consumable sales. Clinical trainer / SME: Intra Aortic Balloon Pump (IABP) theory and practice.

Project Manager: Owner built custom home in Eustis Florida.

Designed, manufactured and distributed unique line of UV (sun) protective swimwear.

Employed at various large academic institutions as well as smaller acute care facilities globally. Australia, Saudi Arabia, London, and USA.